Access Resources
7101 - 7150 of 7540 Results
Title
Year
-
RESTRICTEDTitle: Pathways towards an effective immunotherapy for Parkinson’s diseaseJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 11Issue #: 12Start Page: 1703End Page: 1715Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1586/ern.11.163Best OA location URL: https://europepmc.org/articles/pmc3263336?pdf=renderCitation Count: 27
-
RESTRICTEDTitle: Repeatability of Aerobic Capacity Measurements in Parkinson DiseaseJournal Name: Medicine & Science in Sports & ExercisePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 43Issue #: 12Start Page: 2381End Page: 2387Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1249/mss.0b013e31822432d4Best OA location URL: https://journals.lww.com/acsm-msse/fulltext/2011/12000/repeatability_of_aerobic_capacity_measurements_in.20.aspxCitation Count: 39
-
RESTRICTEDTitle: Sertraline for the Treatment of Depression in Alzheimer Disease: Genetic InfluencesJournal Name: Journal of Geriatric Psychiatry and NeurologyPublisher: SAGE PublicationsVol: 24Issue #: 4Start Page: 222End Page: 228Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/0891988711422527Best OA location URL: https://europepmc.org/articles/pmc3535452?pdf=renderCitation Count: 13
- Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: Unexpected ‘molecular switch’ from a closely related mGlu4 positive allosteric modulator2011RESTRICTEDTitle: Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: Unexpected ‘molecular switch’ from a closely related mGlu4 positive allosteric modulatorJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 21Issue #: 23Start Page: 6955End Page: 6959Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2011.09.131Best OA location URL: https://europepmc.org/articles/pmc3319082?pdf=renderCitation Count: 16
-
RESTRICTEDTitle: Panels, Mini-Panels and Study GroupsJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 36Issue #: S1Start Page: S1End Page: S74Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/npp.2011.290Best OA location URL: https://www.nature.com/articles/npp2011290.pdfCitation Count: 0
- Biochemical and Morphological Characterization of the AβPP/PS/Tau Triple Transgenic Mouse Model and Its Relevance to Sporadic Alzheimer's Disease2011RESTRICTEDTitle: Biochemical and Morphological Characterization of the AβPP/PS/Tau Triple Transgenic Mouse Model and Its Relevance to Sporadic Alzheimer's DiseaseJournal Name: Journal of Alzheimer's DiseasePublisher: IOS PressVol: 27Issue #: 2Start Page: 361End Page: 376Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jad-2011-110608Best OA location URL: https://europepmc.org/articles/pmc3327160?pdf=renderCitation Count: 17
-
RESTRICTEDTitle: CNTRICS Imaging Biomarkers Final Task Selection: Long-Term Memory and Reinforcement LearningJournal Name: Schizophrenia BulletinPublisher: Oxford University Press (OUP)Vol: 38Issue #: 1Start Page: 62End Page: 72Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/schbul/sbr168Best OA location URL: https://academic.oup.com/schizophreniabulletin/article-pdf/38/1/62/5351297/sbr168.pdfCitation Count: 25
-
RESTRICTEDTitle: Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 20Start Page: 1801End Page: 1807Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318237f649Best OA location URL: https://europepmc.org/articles/pmc3233207?pdf=renderCitation Count: 44
-
RESTRICTEDTitle: Quantitative telemedicine ratings in Batten disease: Implications for rare disease researchJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 20Start Page: 1808End Page: 1811Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182377e29Best OA location URL: https://europepmc.org/articles/pmc3233206?pdf=renderCitation Count: 23
-
RESTRICTEDTitle: Solvent exposures and parkinson disease risk in twinsJournal Name: Annals of NeurologyPublisher: WileyVol: 71Issue #: 6Start Page: 776End Page: 784Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.22629Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/92108/1/22629_ftp.pdfCitation Count: 132
- CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease2011RESTRICTEDTitle: CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative diseaseJournal Name: Integrative BiologyPublisher: Oxford University Press (OUP)Vol: 3Issue #: 12Start Page: 1188End Page: 1196Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1039/c1ib00018gBest OA location URL: https://europepmc.org/articles/pmc3334303?pdf=renderCitation Count: 76
- Evidence-based guideline update: Treatment of essential tremor: Report of the Quality Standards Subcommittee of the American Academy of Neurology2011RESTRICTEDTitle: Evidence-based guideline update: Treatment of essential tremor: Report of the Quality Standards Subcommittee of the American Academy of NeurologyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 19Start Page: 1752End Page: 1755Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318236f0fdBest OA location URL: https://n.neurology.org/content/neurology/77/19/1752.full.pdfCitation Count: 260
- A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patients2011RESTRICTEDTitle: A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patientsJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 310Issue #: 1-2Start Page: 248End Page: 250Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2011.05.021Citation Count: 35
- Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets2011RESTRICTEDTitle: Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and plateletsJournal Name: Biochimica et Biophysica Acta (BBA) - Molecular Basis of DiseasePublisher: Elsevier BVVol: 1812Issue #: 11Start Page: 1508End Page: 1514Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.bbadis.2011.07.004Best OA location URL: https://doi.org/10.1016/j.bbadis.2011.07.004Citation Count: 50
-
RESTRICTEDTitle: Effects of parkinsonism on health status in welding exposed workersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 17Issue #: 9Start Page: 672End Page: 676Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.05.021Best OA location URL: https://europepmc.org/articles/pmc3200492?pdf=renderCitation Count: 21
- Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: Four cases2011RESTRICTEDTitle: Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: Four casesJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 310Issue #: 1-2Start Page: 100End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2011.06.003Citation Count: 28
-
RESTRICTEDTitle: The role of the basal ganglia in learning and memory: Insight from Parkinson’s diseaseJournal Name: Neurobiology of Learning and MemoryPublisher: Elsevier BVVol: 96Issue #: 4Start Page: 624End Page: 636Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nlm.2011.08.006Best OA location URL: https://europepmc.org/articles/pmc3772079?pdf=renderCitation Count: 148
-
RESTRICTEDTitle: Brain biochemistry in autopsied patients with essential tremorJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 1Start Page: 113End Page: 117Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.24004Best OA location URL: https://europepmc.org/articles/pmc3261329?pdf=renderCitation Count: 47
- Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal Model2011RESTRICTEDTitle: Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal ModelJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 54Issue #: 21Start Page: 7639End Page: 7647Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/jm200956qBest OA location URL: https://europepmc.org/articles/pmc3226828?pdf=renderCitation Count: 53
-
RESTRICTEDTitle: A soluble α-synuclein construct forms a dynamic tetramerJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 108Issue #: 43Start Page: 17797End Page: 17802Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1073/pnas.1113260108Best OA location URL: https://europepmc.org/articles/pmc3203798?pdf=renderCitation Count: 409
- Relationship Between CSF Biomarkers of Alzheimer's Disease and Rates of Regional Cortical Thinning in ADNI Data2011RESTRICTEDTitle: Relationship Between CSF Biomarkers of Alzheimer's Disease and Rates of Regional Cortical Thinning in ADNI DataJournal Name: Journal of Alzheimer's DiseasePublisher: IOS PressVol: 26Issue #: s3Start Page: 77End Page: 90Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jad-2011-0006Best OA location URL: https://europepmc.org/articles/pmc4587763?pdf=renderCitation Count: 43
-
RESTRICTEDTitle: α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's DiseaseJournal Name: Pharmacological ReviewsPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 63Issue #: 4Start Page: 938End Page: 966Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1124/pr.110.003269Best OA location URL: https://europepmc.org/articles/pmc3186078?pdf=renderCitation Count: 171
- Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study2011RESTRICTEDTitle: Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 10Issue #: 10Start Page: 898End Page: 908Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(11)70175-2Best OA location URL: https://research-repository.griffith.edu.au/bitstream/10072/43372/1/MellickPUB8.pdfCitation Count: 284
-
RESTRICTEDTitle: Cell Therapeutics in Parkinson’s DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 8Issue #: 4Start Page: 539End Page: 548Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-011-0069-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-011-0069-6.pdfCitation Count: 81
-
RESTRICTEDTitle: Plasticity in Early Alzheimer DiseaseJournal Name: Topics in Geriatric RehabilitationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 27Issue #: 4Start Page: 257End Page: 267Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/tgr.0b013e31821e588eBest OA location URL: https://europepmc.org/articles/pmc3419487?pdf=renderCitation Count: 31
-
RESTRICTEDTitle: Regulation of myocyte enhancer factor-2 transcription factors by neurotoxinsJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 32Issue #: 5Start Page: 563End Page: 566Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2011.05.019Best OA location URL: https://europepmc.org/articles/pmc3200477?pdf=renderCitation Count: 15
- Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders2011RESTRICTEDTitle: Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disordersJournal Name: Biochemical PharmacologyPublisher: Elsevier BVVol: 82Issue #: 8Start Page: 873End Page: 882Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bcp.2011.06.001Best OA location URL: https://europepmc.org/articles/pmc3264546?pdf=renderCitation Count: 75
- Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor2011RESTRICTEDTitle: Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factorJournal Name: NeurosciencePublisher: Elsevier BVVol: 194Issue #:Start Page: 220End Page: 226Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2011.07.072Best OA location URL: https://europepmc.org/articles/pmc3408714?pdf=renderCitation Count: 33
-
RESTRICTEDTitle: β-Hexachlorocyclohexane levels in serum and risk of Parkinson's diseaseJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 32Issue #: 5Start Page: 640End Page: 645Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2011.04.002Best OA location URL: https://doi.org/10.1016/j.neuro.2011.04.002Citation Count: 51
-
RESTRICTEDTitle: Apathy and Depression: Separate Factors in Parkinson's DiseaseJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 17Issue #: 6Start Page: 1058End Page: 1066Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1017/s1355617711001068Best OA location URL: https://europepmc.org/articles/pmc3302577?pdf=renderCitation Count: 110
-
RESTRICTEDTitle: GFAP mutations, age at onset, and clinical subtypes in Alexander diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 13Start Page: 1287End Page: 1294Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182309f72Best OA location URL: https://europepmc.org/articles/pmc3179649?pdf=renderCitation Count: 195
-
RESTRICTEDTitle: Neurochemical phenotypes of myenteric neurons in the rhesus monkeyJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 519Issue #: 17Start Page: 3387End Page: 3401Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/cne.22679Best OA location URL: https://europepmc.org/articles/pmc4033411?pdf=renderCitation Count: 21
-
RESTRICTEDTitle: Subthalamic nucleus stimulation reverses mediofrontal influence over decision thresholdJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 14Issue #: 11Start Page: 1462End Page: 1467Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nn.2925Best OA location URL: https://europepmc.org/articles/pmc3394226?pdf=renderCitation Count: 535
- Association of SNCA with Parkinson: Replication in the Harvard NeuroDiscovery Center Biomarker Study2011RESTRICTEDTitle: Association of SNCA with Parkinson: Replication in the Harvard NeuroDiscovery Center Biomarker StudyJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 12Start Page: 2283End Page: 2286Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23934Best OA location URL: https://europepmc.org/articles/pmc3337217?pdf=renderCitation Count: 21
- BAX inhibitor-1 regulates autophagy by controlling the IRE1α branch of the unfolded protein response2011RESTRICTEDTitle: BAX inhibitor-1 regulates autophagy by controlling the IRE1α branch of the unfolded protein responseJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 30Issue #: 21Start Page: 4465End Page: 4478Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/emboj.2011.318Best OA location URL: https://europepmc.org/articles/pmc3230375?pdf=renderCitation Count: 106
- Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding Activities2011RESTRICTEDTitle: Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding ActivitiesJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 412Issue #: 1Start Page: 94End Page: 110Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2011.07.033Best OA location URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158845/pdf/nihms313870.pdfCitation Count: 115
-
RESTRICTEDTitle: Drug Targets from Genetics: Alpha-SynucleinJournal Name: CNS & Neurological Disorders - Drug TargetsPublisher: Bentham Science Publishers Ltd.Vol: 10Issue #: 6Start Page: 712End Page: 723Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/187152711797247867Best OA location URL: https://europepmc.org/articles/pmc3364517?pdf=renderCitation Count: 10
- Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitors2011RESTRICTEDTitle: Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitorsJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 64Issue #: 3Start Page: 268End Page: 273Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.phrs.2011.03.017Citation Count: 50
-
RESTRICTEDTitle: Familial Aggregation of Panic Disturbances in Parkinson's DiseaseJournal Name: Journal of NeuropsychiatryPublisher: American Psychiatric Association PublishingVol: 23Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1176/appi.neuropsych.23.4.417Best OA location URL: https://europepmc.org/articles/pmc3547673?pdf=renderCitation Count: 0
-
RESTRICTEDTitle: Induction of pluripotent stem cells from autopsy donor-derived somatic cellsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 502Issue #: 3Start Page: 219End Page: 224Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2011.07.048Best OA location URL: https://europepmc.org/articles/pmc3195418?pdf=renderCitation Count: 25
-
RESTRICTEDTitle: Lrrk2 p.Q1111H substitution and Parkinson’s disease in Latin AmericaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 17Issue #: 8Start Page: 629End Page: 631Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.05.003Best OA location URL: https://europepmc.org/articles/pmc3167927?pdf=renderCitation Count: 14
-
RESTRICTEDTitle: Serotonergic mediated body mass index changes in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 43Issue #: 3Start Page: 609End Page: 615Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2011.05.009Citation Count: 40
-
RESTRICTEDTitle: Translation Initiator EIF4G1 Mutations in Familial Parkinson DiseaseJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 89Issue #: 3Start Page: 398End Page: 406Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.ajhg.2011.08.009Best OA location URL: http://www.cell.com/article/S0002929711003594/pdfCitation Count: 255
-
RESTRICTEDTitle: Network correlates of the cognitive response to levodopa in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 9Start Page: 858End Page: 865Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31822c6224Best OA location URL: https://europepmc.org/articles/pmc3162641?pdf=renderCitation Count: 61
-
RESTRICTEDTitle: Neurologist care in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 9Start Page: 851End Page: 857Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31822c9123Best OA location URL: https://europepmc.org/articles/pmc3162639?pdf=renderCitation Count: 229
-
RESTRICTEDTitle: Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locusJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1038/ncomms1453Best OA location URL: https://www.nature.com/articles/ncomms1453.pdfCitation Count: 405
- Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging2011RESTRICTEDTitle: Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imagingJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 1Start Page: 90End Page: 97Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23917Best OA location URL: https://europepmc.org/articles/pmc4472452?pdf=renderCitation Count: 165
- Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium2011RESTRICTEDTitle: Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortiumJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 307Issue #: 1-2Start Page: 22End Page: 29Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2011.05.031Best OA location URL: https://europepmc.org/articles/pmc3155471?pdf=renderCitation Count: 43
-
RESTRICTEDTitle: Cdk5: Mediator of neuronal development, death and the response to DNA damageJournal Name: Mechanisms of Ageing and DevelopmentPublisher: Elsevier BVVol: 132Issue #: 8-9Start Page: 389End Page: 394Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.mad.2011.04.011Best OA location URL: https://europepmc.org/articles/pmc3179526?pdf=renderCitation Count: 25
-
RESTRICTEDTitle: CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1408Issue #:Start Page: 88End Page: 97Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2011.06.057Best OA location URL: https://europepmc.org/articles/pmc4120020?pdf=renderCitation Count: 60